Page last updated: 2024-08-24

venlafaxine hydrochloride and Atrophy

venlafaxine hydrochloride has been researched along with Atrophy in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	3 (75.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Blair, IA; Cohen, L; Fiedler, T; Fredricks, DN; Freeman, EW; Guthrie, KA; Hoffman, NG; Joffe, H; LaCroix, AZ; Liu, C; Mitchell, CM; Munch, M; Newton, K; Plantinga, A; Reed, SD; Srinivasan, S; Wu, MC	1
Crider, M; Hill, DA; Hill, SR	1
Osterfeld, ND; Uttner, I; Wolf, RC	1
Bourgeois, JA; Brunberg, JA; Farzin, F; Hagerman, P; Hagerman, R; Hessl, D; Tassone, F; Zhang, L	1

Reviews

1 review(s) available for venlafaxine hydrochloride and Atrophy

Article	Year
Hormone Therapy and Other Treatments for Symptoms of Menopause. American family physician, 2016, Dec-01, Volume: 94, Issue:11 Topics: Acupuncture Therapy; Administration, Intravaginal; Amines; Antidepressive Agents; Atrophy; Cyclohexanecarboxylic Acids; Dietary Supplements; Drug Therapy, Combination; Dyspareunia; Estrogen Replacement Therapy; Estrogens; Exercise Therapy; Female; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Hypnosis; Indoles; Menopause; Paroxetine; Progestins; Selective Estrogen Receptor Modulators; Tamoxifen; Vagina; Vaginal Diseases; Vasomotor System; Venlafaxine Hydrochloride	2016

Article

Year

Hormone Therapy and Other Treatments for Symptoms of Menopause.

American family physician, 2016, Dec-01, Volume: 94, Issue:11

Topics: Acupuncture Therapy; Administration, Intravaginal; Amines; Antidepressive Agents; Atrophy; Cyclohexanecarboxylic Acids; Dietary Supplements; Drug Therapy, Combination; Dyspareunia; Estrogen Replacement Therapy; Estrogens; Exercise Therapy; Female; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Hypnosis; Indoles; Menopause; Paroxetine; Progestins; Selective Estrogen Receptor Modulators; Tamoxifen; Vagina; Vaginal Diseases; Vasomotor System; Venlafaxine Hydrochloride

2016

Trials

1 trial(s) available for venlafaxine hydrochloride and Atrophy

Article	Year
Associations between improvement in genitourinary symptoms of menopause and changes in the vaginal ecosystem. Menopause (New York, N.Y.), 2018, Volume: 25, Issue:5 Topics: Antidepressive Agents, Second-Generation; Atrophy; Dyspareunia; Estradiol; Estrogens; Female; Glycogen; Humans; Lactobacillus; Longitudinal Studies; Microbiota; Middle Aged; Postmenopause; Surveys and Questionnaires; Vagina; Vaginal Diseases; Venlafaxine Hydrochloride; Vulvar Diseases	2018

Article

Year

Associations between improvement in genitourinary symptoms of menopause and changes in the vaginal ecosystem.

Menopause (New York, N.Y.), 2018, Volume: 25, Issue:5

Topics: Antidepressive Agents, Second-Generation; Atrophy; Dyspareunia; Estradiol; Estrogens; Female; Glycogen; Humans; Lactobacillus; Longitudinal Studies; Microbiota; Middle Aged; Postmenopause; Surveys and Questionnaires; Vagina; Vaginal Diseases; Venlafaxine Hydrochloride; Vulvar Diseases

2018

Other Studies

2 other study(ies) available for venlafaxine hydrochloride and Atrophy

Article	Year
[Depressive symptoms in a case of "posterior cortical atrophy"]. Fortschritte der Neurologie-Psychiatrie, 2010, Volume: 78, Issue:4 Topics: Affect; Antidepressive Agents, Second-Generation; Atrophy; Brain Diseases; Cerebral Cortex; Cognition Disorders; Cyclohexanols; Depressive Disorder; Electroencephalography; Evoked Potentials; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neurodegenerative Diseases; Positron-Emission Tomography; Venlafaxine Hydrochloride	2010
Dementia with mood symptoms in a fragile X premutation carrier with the fragile X-associated tremor/ataxia syndrome: clinical intervention with donepezil and venlafaxine. The Journal of neuropsychiatry and clinical neurosciences, 2006,Spring, Volume: 18, Issue:2 Topics: Aged; Antidepressive Agents, Second-Generation; Ataxia; Atrophy; Brain; Cyclohexanols; Dementia; Dominance, Cerebral; Donepezil; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fragile X Mental Retardation Protein; Fragile X Syndrome; Genetic Carrier Screening; Humans; Image Processing, Computer-Assisted; Indans; Magnetic Resonance Imaging; Male; Mental Status Schedule; Mood Disorders; Neurologic Examination; Neuropsychological Tests; Nootropic Agents; Piperidines; Tremor; Trinucleotide Repeats; Venlafaxine Hydrochloride	2006

Article

Year

[Depressive symptoms in a case of "posterior cortical atrophy"].

Fortschritte der Neurologie-Psychiatrie, 2010, Volume: 78, Issue:4

Topics: Affect; Antidepressive Agents, Second-Generation; Atrophy; Brain Diseases; Cerebral Cortex; Cognition Disorders; Cyclohexanols; Depressive Disorder; Electroencephalography; Evoked Potentials; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neurodegenerative Diseases; Positron-Emission Tomography; Venlafaxine Hydrochloride

2010

Dementia with mood symptoms in a fragile X premutation carrier with the fragile X-associated tremor/ataxia syndrome: clinical intervention with donepezil and venlafaxine.

The Journal of neuropsychiatry and clinical neurosciences, 2006,Spring, Volume: 18, Issue:2

Topics: Aged; Antidepressive Agents, Second-Generation; Ataxia; Atrophy; Brain; Cyclohexanols; Dementia; Dominance, Cerebral; Donepezil; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fragile X Mental Retardation Protein; Fragile X Syndrome; Genetic Carrier Screening; Humans; Image Processing, Computer-Assisted; Indans; Magnetic Resonance Imaging; Male; Mental Status Schedule; Mood Disorders; Neurologic Examination; Neuropsychological Tests; Nootropic Agents; Piperidines; Tremor; Trinucleotide Repeats; Venlafaxine Hydrochloride

2006